Search hospitals > Wisconsin > Sturgeon Bay
Saint Vincent Hospital Cancer Center at Sturgeon Bay
Claim this profileSturgeon Bay, Wisconsin 54235
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Tumors
137 reported clinical trials
4 medical researchers
Summary
Saint Vincent Hospital Cancer Center at Sturgeon Bay is a medical facility located in Sturgeon Bay, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Tumors and other specialties. Saint Vincent Hospital Cancer Center at Sturgeon Bay is involved with conducting 137 clinical trials across 339 conditions. There are 4 research doctors associated with this hospital, such as Matthew L. Ryan, Brian L. Burnette, Anthony J. Jaslowski, and Catherine A. Long.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Matthew L. RyanSaint Vincent Hospital Cancer Center Green Bay1 year of reported clinical research
Expert in Cancer
Studies Recurrence
45 reported clinical trials
103 drugs studied
Brian L. BurnetteSaint Vincent Hospital Cancer Center Green Bay4 years of reported clinical research
Expert in Cancer
Studies Breast Cancer
30 reported clinical trials
82 drugs studied
Anthony J. JaslowskiSaint Vincent Hospital Cancer Center Green Bay5 years of reported clinical research
Expert in Cancer
Studies Breast Cancer
23 reported clinical trials
42 drugs studied
Catherine A. LongSaint Vincent Hospital Cancer Center Green Bay4 years of reported clinical research
Studies Tumors
Studies Cancer
21 reported clinical trials
56 drugs studied
Clinical Trials running at Saint Vincent Hospital Cancer Center at Sturgeon Bay
Breast Cancer
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Diffuse Large B-Cell Lymphoma
Melanoma
Squamous Cell Carcinoma
Multiple Myeloma
Tumors
Recurrence
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Vincent Hospital Cancer Center at Sturgeon Bay?
Saint Vincent Hospital Cancer Center at Sturgeon Bay is a medical facility located in Sturgeon Bay, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Tumors and other specialties. Saint Vincent Hospital Cancer Center at Sturgeon Bay is involved with conducting 137 clinical trials across 339 conditions. There are 4 research doctors associated with this hospital, such as Matthew L. Ryan, Brian L. Burnette, Anthony J. Jaslowski, and Catherine A. Long.